Peptide Therapeutics Market Potential Growth, Demand And Analysis Of Key Players- Analysis Forecasts To 2025

 In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide peptide therapeutics market share currently valued at US$ 34.4 billion, is anticipated to grow at a remarkable CAGR of 11% from 2022 to 2025, reaching US$ 47 billion.

Peptide therapeutics demand are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases.

Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of peptide therapeutics is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians.

The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025).

The COVID-19 pandemic has been severely affecting the global economic order, and, in turn, the peptide therapeutics market. Restrictions on traveling, self-quarantines, and social distancing regulations, on a national scale, are resulting in notable drop in business and consumer spending through Q2.

Key Takeaways of Peptide Therapeutics Market Study

  • In terms revenue generation, among the applications, cancer outperformed other application types, owing to greater prevalence of the disease as well as higher efficacy of peptide therapeutics in cancer treatment.
  • Various peptide therapeutics are patented, and, in the mid of this decade, a majority of these patents are expected to reach their expiry dates, leading to higher generic competition.
  • Parenteral route continues to hold the leading revenue share in the peptide therapeutics market, owing to effective drug delivery and higher therapeutic index.

Key Players Focus on Strategic Collaborations and Generic Launches to Widen Regional Presence

Top peptide therapeutics companies are:

Eli Lilly and Company
AstraZeneca plc
Merck & Co. Inc
Ipsen S.A
Novo Nordisk A/S
Teva Pharmaceutical Industries Ltd. 

are concentrating on business expansions through joint ventures and distribution agreements, and are capturing untapped market potential.

Additionally, market incumbents are entering into collaborations in order to expand their regional presence and manufacturing capabilities in the global peptide therapeutics market.

More Valuable Insights on Peptide Therapeutics Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2014 to 2025. The global peptide therapeutics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

For more Information @ https://www.futuremarketinsights.com/reports/peptide-therapeutics-market 

The study provides compelling insights on the peptide therapeutics market on the basis of application, (cancer, cardiovascular diseases, central nervous systems, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, dermatology, respiratory disorders, acromegaly, and other applications), route of administration (parenteral route, mucosal route, oral route, and transdermal route), and marketing (branded and generic), across seven major regions.

Key Segments Of Peptide Therapeutics Market Industry Survey

By Application :

  • Cancer
  • Cardiovascular Diseases
  • Central Nervous Systems
  • Metabolic Disorders
  • Infections
  • Hematological Disorders
  • Gastrointestinal Disorders
  • Dermatology
  • Respiratory Disorders
  • Acromegaly
  • Other Applications

By Route of Administration :

  • Parenteral Route of Administration
  • Mucosal Route of Administration
  • Oral Route of Administration
  • Transdermal of Route Administration

By Drug Type :

  • Branded Drugs
  • Generic/Biosimilar Drugs

Comments

Post a Comment

Popular posts from this blog

Mammography Market Demand, Scope and Future Estimation until 2032

  The global  mammography market    is estimated to be worth around  US$ 1.7 Billion  in 2022. However, with rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around  6.5%  to  9% CAGR  between 2022 and 2032, totaling over  US$ 3.4 Billion  by 2032. Mammography  is a modern non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to monitor breast tissues for the presence of tumor. It has become one of the most commonly used techniques for checking abnormalities in the absence of any symptoms. It has significantly aided in reducing breast cancer mortality rates worldwide. Increasing prevalence of breast cancer across the world along with growing awareness about the benefits of screening and early diagnosis of breast cancer is providing a major impetus to the growth of mammography market. It is one of the most common f...
Read more

Interventional Cardiology Devices Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The  interventional cardiology devices market demand  is expected to grow at an  8.4%  CAGR from  USD 16.4  Billion in 2022 to USD  36.9  Billion by 2032. The fast expansion of the geriatric population and the corresponding increase in the prevalence of coronary artery diseases, the approval of new and sophisticated products, and the growing incidence of diabetes are all driving growth in the interventional cardiology devices market. However, the availability of alternative therapies, as well as product failures and recalls, are the primary factors projected to hinder interventional cardiology devices market growth over the projection period. COVID-19 has had a global influence on every element of the medical device business, including the market for interventional cardiology equipment. Despite the fact that emergency and outpatient treatments are offered in cardiology departments, the number of patient visits to hospitals has decreased dra...
Read more

Cardiac Rehabilitation Market Research, Segmentation, Key Players Analysis & Forecast By 2032

  The  cardiac rehabilitation market share  is likely to expand its roots in the global market at an average CAGR of 6.0% between 2022 and 2032. The market is valued at US$ 2.1 Bn in 2022 and is likely to reach US$ 3.8 Bn by 2032. Previously, the market was thriving at a slightly higher CAGR of 6.5% (2015-2021), ensuring a market size of US$ 2 Billion in 2021. “Growing lifestyle-related diseases like diabetes and cardiovascular strokes along with the technological revolution in the healthcare sector, helping the patients going through heart attack, heart valve surgeries, heart failures.” An unhealthy lifestyle is leading to new heart-related diseases like heart attacks and heart failure. The technologically advanced tools that enable easy surgery processes drive the sales of cardiac rehabilitation systems. These systems help end users with exercises, diet, stress management and training, managing and monitoring the daily progress of the health routine. It is largely consu...
Read more